Predictive and prognostic value of FDG-PET

Area of Science:

• Oncology
• Nuclear Medicine
• Radiology

Background:

• Fluorodeoxyglucose-positron emission tomography (FDG-PET) is increasingly utilized in cancer diagnostics.
• Its predictive and prognostic capabilities are crucial for treatment planning and outcome assessment.

Purpose of the Study:

• To review the predictive and prognostic value of FDG-PET in non-small-cell lung carcinoma (NSCLC), colorectal carcinoma, and lymphoma.
• To discuss the role of FDG uptake in various stages of cancer, including initial presentation, post-treatment, and relapse.

Main Methods:

• Review of existing literature on FDG-PET applications in NSCLC, colorectal carcinoma, and lymphoma.
• Analysis of FDG uptake as a prognostic indicator at different time points in cancer treatment.

Main Results:

• FDG uptake is prognostic in NSCLC at initial presentation, post-induction therapy, and upon relapse.
• FDG-PET predicts clinical outcomes in locally advanced and advanced NSCLC early in treatment.
• FDG-PET shows potential in monitoring local therapies and predicting response to treatments in colorectal carcinoma.
• End-of-treatment FDG-PET is prognostic for FDG-avid lymphomas, with interim PET predicting remission.

Conclusions:

• FDG-PET is a valuable tool for predicting outcomes and monitoring treatment response in NSCLC, colorectal carcinoma, and lymphoma.
• Standardized interpretation guidelines are being introduced to reduce variability in FDG-PET studies.
• Further research and systematic inclusion in therapeutic trials are essential to optimize FDG-PET's role in cancer management.